Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?

In patients with idiopathic dilated cardiomyopathy treated with pentoxifylline, a reduction in Fas/APO-1 plasma concentrations correlates with improved left ventricular function.